Antibodies are extensively used in many biochemical and immunological studies. The recent development of efficient and rapid methods for expression and purification of large quantities of desired proteins provides a convenient source of immunogen for antibody production. One commonly used expression system is the glutathione Stransferase (GST)-fusion bacterial expression system. It produces a large quantity of a desired protein fused to the C terminus of GST and can be easily purified in a single step (6). The GSTfusion polypeptides have been successfully used for antiserum production (2,3,5,7). We have previously shown that affinity-matrix-bound GST fusion protein is a significantly better immunogen than the eluted fusion protein (5). Thus, the affinity matrix can be used not only to minimize the number of protein purification steps but also to enhance the antigenicity of the immunogen.
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An alternative to expression and/or purification of proteins as immunogens is the use of synthetic peptides. However, because of their small size, peptides are generally not good immunogens. To enhance immunogenicity, peptides have been chemically cross-linked to larger carriers such as bovine serum albumin, keyhole limpet hemocyanin or agarose (1) . However, the covalent coupling of peptides to carriers can result in undesirable alterations in peptide structure and limited presentation of the antigenic determinants. Here, we describe a simple modification of synthetic peptides that allows for rapid preparation of multiple peptides as immunogens for antiserum production. We have taken advantage of another commonly used affinity tag that has been extensively used for purification of a large number of proteins, namely the hexahistidine (6 ×His) tag (4) . The desired peptide is synthesized with a 6 × His tag, which provides high-affinity binding to immobilized nickel ions. The nickel ions are tightly bound to the unique nitrilotriacetic acid (NTA) resin, allowing firm binding of the peptide/nickel complex under a variety of conditions (Ni-NTA agarose; Qiagen, Chatsworth, CA, USA). The affinitymatrix-bound peptide is then used directly as an immunogen for antiserum production as described below. This not only eliminates subsequent chemical modification and conjugation of synthetic peptides to enhance their immunogenicity but also provides an affinity matrix for purification of antiserum. The affinity-matrix-bound peptide can also be used for isolating and identifying proteins with which it might interact.
We synthesized a 21 amino acid peptide tagged with six additional histidines at its N terminus (HHHHHHQ-ALGTRATETVYSEIRKVDPK) with a molecular weight of about 3.2 kDa. The purified peptide was dissolved in phosphate-buffered saline (PBS) at approximately 2 mg/mL. To prepare the immunogen for injections, multiple 0.5-mL aliquots containing approximately 200 µ g of peptide each were prepared by mixing 100 µ L of peptide stock with 50-100 µ L of Ni-NTA agarose that was washed twice with PBS and resuspended in 0.4 mL of PBS. This amount of peptide is below the binding capacity of the Ni-NTA matrix. Thus, one could vary the ratio of peptide to beads in order to optimize titer and/or specificity of the resultant antisera. The peptide was allowed to bind to Ni-NTA agarose for 30 min at room temperature and then shipped on wet ice to commercial antibody production facilities. Both chickens (Aves Labs, Tigard, OR, USA) and rabbits (Cocalico Biologicals, Reamstown, PA, USA) were immunized according to their standard protocols for antiserum production. The animals were injected subcutaneously with a four injection series that ran 6 (for chickens) to 8 (for rabbits) weeks. The first injection was 200 µ g of antigen (the affinity-matrixbound peptide, 0.5 mL) mixed with complete Freund's adjuvant (0.5 mL). The same amount of antigen mixed with incomplete Freund's adjuvant was injected for the boosters. Following the second boost, the antiserum levels were examined by enzyme-linked immunosorbent assay and immunoblot analysis. The animals were boosted again one week before completion of the protocol. We successfully obtained specific anti-peptide antisera in both hosts. Figure 1 illustrates an immunoblot analysis using the antisera prepared from a chicken and a rabbit injected with the immobilized peptide. The antisera from both hosts appeared to specifically recognize proteins that contained the amino acid sequence present in the immunogen and not proteins that lacked these sequences ( Figure 1, A and  B) . The rabbit antiserum also recognized the original protein from which the peptide sequence was derived, expressed in two different cell lines, under both reduced and nonreduced conditions ( Figure 1C ). The dilutions of antisera used in Western blots varied by approximately twofold among the three animals of each species. The dilutions of rabbit antisera were in the range of 1:5000 to 1:20 000. These are comparable to, if not better than, dilutions of other purified polyclonal antibodies used in our laboratory. The chicken antisera were used at higher concentrations and gave higher backgrounds in immunoblots compared to rabbit antisera (Figure 1, compare A and B) . However, antisera from all the animals did detect nanogram quantities of the purified recombinant proteins that contained the antigen peptide sequence. The preincubation of immunogenic peptide with the antisera before immunoblotting demonstrated specificity by preventing the detection of desired polypeptides (not shown). The 6 ×His tag, because of its small size (0.84 kDa), is poorly immunogenic in most species (4). The antisera prepared here did not recognize microgram amounts of 6 ×His-tagged dihydrofolate reductase (DHFR) protein in Western blots, indicating a lack of antigenic response to the 6 × His tag (not shown). Thus, the histidine-tagged synthetic peptide bound to the Ni-NTA matrix resulted in an antigenic response in two different host species, generating specific antisera. We believe this simple modification can be applied to any peptide, facilitating direct use of peptides as 30BioTechniques
Vol. 25, No. 1 (1998) immunogens. Using this method, we have recently prepared antisera to three other histidine-tagged peptides. In summary, we describe a simple modification to synthesis of peptides that allows their rapid and simple preparation as immunogens. The histidine affinity tag, which can be placed at either end of the peptide, allows binding of the peptides to the affinity matrix and eliminates the need for subsequent chemical modification and conjugation to enhance immunogenicity. The flexibility of partially immobilized peptide can also result in greater presentation of antigenic determinants and generation of antibodies reactive with both native and denatured forms of antigen. In addition, the affinity matrix can be used for further purification of the antibody. Therefore, this procedure provides a useful alternative to other methods currently used.
